SESSION 9 SCHEDULE
Thursday
SESSION 9: TOPICS OF INTEREST TO INTERVENTIONALISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS: ENDOVASCULAR HEART VALVES, ASCENDING AORTA AND ARCH LESIONS, IN SITU FENESTRATION, IMPROVED OPEN SURGICAL APPROACHES
xxxx
Moderators:TBD
x
6:35 AM - 6:40 AM Opening Remarks
 
6:40 AM - 6:45 AM Training Issues In Cardiac Surgery
  Presenters(s):Grayson H. Wheatley, MD  
6:46 AM - 6:51 AM Access Problems With Endovascular Aortic Valve Repair And How To Handle Them
 
6:52 AM - 6:57 AM Updated Experience With The Percutaneous Self-Expanding CORE Aortic Valve
 
6:58 AM - 7:03 AM Current State-of-the-Art With Endovascular Aortic Valve Repair
  Presenters(s):Martin B. Leon, MD  
7:04 AM - 7:09 AM Overview Of Percutaneous And Other Less Invasive Mitral Valve Treatments
  Presenters(s):Ted Feldman, MD  
7:10 AM - 7:15 AM The Future For Endovascular Repair Of Type A Aortic Dissections: Concept And Initial Clinical Experience
 
7:16 AM - 7:22 AM Panel Discussion
7:22 AM - 7:27 AM Where Are We With Branched Grafts For Treatment Of Aortic Arch Lesions?
 
7:28 AM - 7:33 AM Aortic External Graft Wrapping Makes Hybrid Procedures Successful And The Best Treatment For Aortic Arch Pathology: Technical Tips For Doing It Right
 
7:34 AM - 7:39 AM Open Repair Is Still The Best Option For Arch Aneurysms In Most Patients
  Presenters(s):Hazim J. Safi, MD  
7:40 AM - 7:45 AM Aortic Arch And TAA Repair Via A Left Thoracotomy: A New Technique
 
7:46 AM - 7:51 AM Is In Situ Fenestration The Way To Go For Revascularization Of Supra-Aortic Branches In Association With Endovascular Repair Of Arch Aneurysms?
 
7:52 AM - 7:57 AM Endovascular Total Arch Replacement Using In Situ Fenestration Methods: Techniques, Tricks And Early Clinical Experience
  Presenters(s):Bjõrn Sonesson, MD, PhD  
7:58 AM - 8:04 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Thursday
SESSION 10: MORE ABOUT THORACIC ENDOGRAFTING AND TREATMENT OF DISSECTING ANEURYSMS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
8:04 AM - 8:09 AM What Is Optimal Medical Treatment For Type B Aortic Dissections: How Well Does It Work?
  Presenters(s):Christoph A. Nienaber, MD, PhD  
8:10 AM - 8:15 AM Debate 1: All Acute Type B Aortic Dissections Should Be Treated With An Endograft: We Don’t Need Level I Evidence
 
8:16 AM - 8:21 AM Debate 1: Nonsense, We Do Need Level I Evidence Comparing Medical Treatment With TEVAR For Uncomplicated Type B Aortic Dissection: Early Results Of Such A Trial (The ADSORB Trial)
 
8:22 AM - 8:27 AM Lessons Learned In Endograft Treatment Of More Than 550 Patients With Type B Aortic Dissections: How To Manage Retrograde Type A Dissections
  Presenters(s):Wei Guo Fu, MD  
8:28 AM - 8:33 AM Debate 2: For Type B Aortic Dissections Short TEVAR Coverage Of The Primary Tear Is Best
 
8:34 AM - 8:39 AM Debate 2: For Type B Aortic Dissections TEVAR Should Cover The Entire Thoracic Aorta
 
8:40 AM - 8:45 AM Oral Anticoagulation In Type B Aortic Dissections Has A Beneficial Effect On Secondary Dilatation And Malperfusion
 
8:46 AM - 8:51 AM Potential Devices For Complete Endovascular Repair Of Complex Type B Aortic Dissecting Aneurysms: The Hollow Hat Small Endograft For Leaks At Branch Reentry Sites
  Presenters(s):Zaiping Jing, MD  
8:52 AM - 8:57 AM Experience With Endo TAA Repair With Branched Endografts: When Can This Technology Not Be Used?
 
8:58 AM - 9:03 AM Single Center Experience With Treatment Of Malperfusion From Type B Aortic Dissections
 
9:04 AM - 9:10 AM Panel Discussion
END OF SESSION 10
 
SESSION 11 SCHEDULE
Thursday
SESSION 11: NEW DEVELOPMENTS AND TECHNIQUES IN TEVAR AND DEALING WITH ITS COMPLICATIONS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
9:10 AM - 9:15 AM Debate 3: Left Subclavian Artery Coverage During TEVAR Is Relatively Safe: When Is It Not?
 
9:16 AM - 9:21 AM Debate 3: Left Subclavian Artery Flow Must Be Preserved During TEVAR: If Covered The Left Subclavian Must Be Revascularized
 
9:22 AM - 9:27 AM Management Of Recurrent Aneurysms After TEVAR From Endograft Failure Or Disease Progression
  Presenters(s):Geoffrey H. White, MD  
9:28 AM - 9:33 AM What Are Malignant Aortic Dissections And How Are They Best Treated Endovascularly: The MAD REDEEM Concept
  Presenters(s):Christoph A. Nienaber, MD, PhD  
9:34 AM - 9:39 AM Direct Placement Of Large Sheaths In The Aorta Or Common Iliacs For TEVAR: Techniques And Tricks For Doing It Safely
 
9:40 AM - 9:45 AM Computational Hemodynamics And Its Importance In Acute Thoracic Aortic Disease
 
9:46 AM - 9:51 AM New Endovascular Procedures For Better Treatment Of Chronic Type B Dissections With Aneurysm Formation
 
9:52 AM - 9:57 AM TEVAR After Previous AAA Repair Is Relatively Safe: When Is Spinal Drainage Necessary?
 
9:58 AM - 10:03 AM A Blood Test For Thoracic Aortic Aneurysms
 
10:04 AM - 10:09 AM Use Of Atrium ICAST Covered Stents To Treat Aortic Coarctation And Associated Aneurysms: Are They Safer Than Bare Stents?
 
10:10 AM - 10:18 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Thursday
SESSION 12: HOT TOPICS IN LOWER EXTREMITY ENDOVASCULAR TREATMENT (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
6:40 AM - 6:45 AM Opening Remarks
 
6:45 AM - 6:50 AM Overview Of Atherectomy Devices: What Is The Evidence They Add Anything But Cost?
 
6:51 AM - 6:56 AM Debate 4: Rotational Atherectomy Devices Really Work In Certain Specific Situations: What Are They? What Is The Proof?
 
6:57 AM - 7:03 AM Debate 4: Atherectomy Devices Are A Waste Of Time And Money
 
7:04 AM - 7:09 AM Value And Limitations Of The ANGIOSCULPT Scoring/Cutting PTA Balloon For Infrapopliteal Lesions: 2-Year Results Of The MASCOT Trial: Will This Decrease The Need For Stents?
 
7:10 AM - 7:15 AM Cool Excimer Laser Assisted PTA vs. Balloon PTA With New Improved Balloons For Tibial Occlusive Disease Causing Critical Limb Ischemia (CLI): Is The Laser Of Real Value And When?
 
7:16 AM - 7:21 AM Tips, Tricks And Bailout Strategies For Subintimal Angioplasty Of Long Infrainguinal Occlusions
 
7:22 AM - 7:27 AM Debate 5: Update And 12-Month Results With Drug Eluting Balloons Show Clear Benefit For Treating SFA And Popliteal Lesions
 
7:28 AM - 7:33 AM Debate 5: It Is Not So Clear That Drug Eluting Balloons Work
 
7:34 AM - 7:39 AM Prevention And Treatment Of In-Stent Restenosis
 
7:40 AM - 7:45 AM Will Long Nitinol Stents (Like the 20 cm EVERFLEX) Replace Bypass Surgery For Long Fempop Occlusions?
 
7:46 AM - 7:58 AM Panel Discussion
END OF SESSION 12
 
SESSION 13 SCHEDULE
Thursday
SESSION 13: MORE LOWER EXTREMITY HOT TOPICS, ESPECIALLY REGARDING STENTS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
7:59 AM - 8:04 AM Role Of Current Stents In Lower Extremity Occlusive Disease In 2009: What Is The Most Recent Evidence Including That From The STRIDES And VIASTAR Studies?
 
8:05 AM - 8:10 AM 2-Year Results Of The ZILVER-PTX Drug-Eluting Stent For SFA Lesions
 
8:11 AM - 8:16 AM Status Of The TURBO BOOSTER Spectranetics Laser For Lower Extremity Occlusive Disease: Has It Changed Things?
 
8:17 AM - 8:22 AM New Concepts In Stent Design: The Micromesh-Covered SESAME Stent: Design And Clinical Experience
 
8:23 AM - 8:28 AM Technical Tips And Results Of Transpedal Approach For Revascularizing Tibial Artery Occlusions Which Cannot Be Crossed From Above
 
8:29 AM - 8:34 AM Indication And Techniques For Transpedal Approach In The Treatment Of Critical Limb Ischemia
 
8:35 AM - 8:40 AM New Technique For Distal PTA Of Tibial Arteries: The Pedal Arch Route For Access: Can It Work In Diabetics?
 
8:41 AM - 8:46 AM Need For Distal Embolic Filtration Devices With Lower Extremity Atherectomy And Laser Angioplasty
 
8:47 AM - 8:52 AM Incidence Of Embolization After Lower Extremity Percutaneous Revascularization
 
8:53 AM - 8:58 AM Choice Of Access For Below-Knee Interventions: Up And Over vs. Antegrade
 
8:59 AM - 9:10 AM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Thursday
SESSION 14: MORE LOWER EXTREMITY HOT TOPICS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
9:10 AM - 9:15 AM Devices And Simplified Strategies For Crossing Total Occlusions
 
9:16 AM - 9:21 AM Value And Limitations Of Drug-Eluting Stents (DES) In The Treatment Of Critical Limb Ischemia (CLI)
 
9:22 AM - 9:27 AM DES vs. Bare Metal Stents (BMS) To Treat Below-Knee Lesions: 1-Year Angiographic Results Of The DESTINY Trial
 
9:28 AM - 9:33 AM Below-Knee DES For CLI: Results With 2-Year Follow-Up
 
9:34 AM - 9:39 AM Intraoperative Stem Cell Treatment Delivered With A Novel Device To Improve Limb Salvage Rates
  Presenters(s):Ralf R. Kolvenbach, MD  
9:40 AM - 9:45 AM Debate 6: DES In The SFA Will Have A Positive Impact
 
9:46 AM - 9:51 AM Debate 6: DES In The SFA Are Not Needed
 
9:52 AM - 9:57 AM 5-Year Results With Zilver Stents Across The Knee Are Good
 
9:58 AM - 10:03 AM With Foot Gangrene And Ulceration Wound Healing Occurs Faster And Better With A Bypass Than With Endovascular Treatments
 
10:04 AM - 10:18 AM Panel Discussion

CONCLUSION OF PROGRAMS A AND B. AIMsymposium continues in the Trianon Ballroom, 3rd Floor as Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor as Plenary Sessions.
END OF SESSION 14
 
SESSION 15 SCHEDULE
Thursday
SESSION 15: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
10:20 AM - 10:25 AM Advanced Interventional Techniques In Fempop And Crural Arteries For CLI: The Role Of Plain Old Balloon PTA (POBA)
 
10:26 AM - 10:31 AM Debate 7: New Developments In Subintimal Angioplasty: It Is A Desirable Method
 
10:32 AM - 10:37 AM Debate 7: Subintimal Angioplasty For CLI Is A Technical Error Not A First Choice Procedure
 
10:38 AM - 10:43 AM Advantages, Disadvantages And Technical Tips For Subintimal Angioplasty
 
10:44 AM - 10:49 AM New Options For Restenosis In The SFA
 
10:50 AM - 10:55 AM ICAST Balloon-Expandable Stents And Covered Stents In The Lower Extremity: Results Of The ICARUS Trial
 
10:56 AM - 11:01 AM Endovascular Methods To Treat Severely Calcified SFAs Successfully
 
11:02 AM - 11:07 AM Panel Discussion
Moderator(s): TBD / TBD  
11:07 AM - 11:12 AM Debate 8: TASC II Is A Good Decision Making Tool
 
11:13 AM - 11:18 AM Debate 8: TASC II Is Too Complicated And Not Worthwhile As A Treatment Guide
 
11:19 AM - 11:24 AM Methods For Stenting Infrainguinal Lesions At Bifurcations Safely And Effectively: Something We All Need To Know
 
11:25 AM - 11:30 AM Stenting Of Lesions At Tibial Bifurcations: Indications And Techniques
 
11:31 AM - 11:36 AM Debate 9: Endovascular Techniques Can Effectively Treat Virtually All Patients With CLI: Open Surgery Is Almost Never Needed
 
11:37 AM - 11:42 AM Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: An Interventionalist’s Perspective
 
11:43 AM - 11:48 AM Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: A Vascular Surgeon’s Perspective
 
11:49 AM - 11:54 AM Debate 9: Open Surgical Bypass Is The Procedure Of Choice For CLI Revascularization
 
11:55 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Served in the Exhibit Hall and in Other Designated Areas
END OF SESSION 15
 
SESSION 16 SCHEDULE
Thursday
SESSION 16: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
1:00 PM - 1:05 PM A New Technique For In Situ Fenestration To Revascularize Aortic Branches Using Electro-Magnetic Navigation
 
1:06 PM - 1:11 PM When Can Type I Endoleaks After EVAR Be Safely Observed?
 
1:12 PM - 1:17 PM How Well Is The Petticoat Concept (Open Stent Distal to a Stent-Graft) Working For Treatment Of Type B Dissections?
  Presenters(s):Christoph A. Nienaber, MD, PhD  
1:18 PM - 1:23 AM Update On The STABLE Trial With A Thoracic Endograft, Comprised Of A Covered Stent Above And An Open Stent Below, For Type B Aortic Dissections
 
1:24 PM - 1:29 PM Experience With Hybrid Grafting Of The Visceral And Renal Arteries From The Ascending Aorta: Is It A Better Way?
 
1:30 PM - 1:35 PM 8-Year Experience With The VORTEC Procedure: Viabahn Technique For Revascularization Of Aortic Branch Vessels Without Clamping Or Circumferential Dissection: Is It A Better Way?
 
1:36 PM - 1:41 PM An Improved Preloaded Fenestrated Endograft For Pararenal AAAs: Advantages, Technical Description And Initial Clinical Experience
 
1:42 PM - 1:47 PM Panel Discussion
Moderator(s): TBD / TBD  
1:47 PM - 1:52 PM Tissue Glue And Coil Embolization For Difficult Type I Endoleaks: Technique And Midterm Results
 
1:53 PM - 1:58 PM Optimal Techniques For Surveillance After EVAR In 2009 And Beyond
 
1:59 PM - 2:04 PM AAA Sac Pressure Measurements Are Helpful Since Many Type II Endoleaks Should Be Treated Because They Can Cause AAA Ruptures
 
2:05 PM - 2:10 PM Technique For Continuous Supraceliac Balloon Aortic Control With Ruptured AAAs And Hemodynamic Collapse (Video Presentation)
 
2:11 PM - 2:16 PM A New System For Electronic Image Marking To Simplify Interventional Procedures
 
2:17 PM - 2:22 PM Is EVAR The Treatment Of Choice For Inflammatory AAAs?
 
2:23 PM - 2:28 PM Panel Discussion
END OF SESSION 16
 
SESSION 17 SCHEDULE
Thursday
SESSION 17: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2009 (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
2:28 PM - 2:33 PM Debate 10: CAS Is Dead Based On Population Based Studies And Level I Evidence
 
2:34 PM - 2:39 PM Debate 10: CAS Is Not Dead: It Will Have A Role In Symptomatic Patients When Used With New And Better Technology (Better Stents/Flow Reversal) And Better Patient Selection
 
2:40 PM - 2:45 PM Anatomic And Lesion Characteristics Are Accurate Predictors Of Stroke From CAS: What Technique Is Best For Determining This?
 
2:46 PM - 2:51 PM New Key Information From The SPACE Trial: Cerebral Protection vs. No Cerebral Protection: Timing Of Strokes With CAS; Incidence Of Restenosis After CAS And CEA; Open vs. Closed Stents – Which Is Best?
 
2:52 PM - 2:58 PM Results Of The ICSS Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic Patients
 
2:59 PM - 3:04 PM 1-Year Results Of The CREST Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic And Asymptomatic Patients
 
3:05 PM - 3:10 PM Where Do We Go From Here With Randomized Trials Of CAS vs. CEA: Do We Need More Trials In Asymptomatic Patients With A Best Medical Treatment Arm; More Trials With Better Patient Selection; Or More Trials With Better Technology For CAS (Flow Reversal and Better Stent Systems)?
 
3:11 PM - 3:16 PM CAS With Proximal Protection (Flow Cessation/Reversal) And Hybrid (Cristallo) Stents: Will This Be A Better And Universally Safe Approach?
 
3:17 PM - 3:22 PM Debate 11: Indirect Markers Of Cerebral Embolization (TCD and Diffusion-Weighted MRI) Are Of Great Value In Differentiating Strategies For Embolic Protection In CAS
 
3:23 PM - 3:28 PM Debate 11: Indirect Markers Of Cerebral Embolization (TCD and DW-MRI) Are Of Little Value In Differentiating Strategies For Embolic Protection In CAS Because Most Strokes With CAS Occur Before Or After Embolic Protection Devices Are Functioning
 
3:29 PM - 3:34 PM Imaging Suite Of The Future Will Combine Many Modalities: What Can Be Combined With Fluoroscopy To Facilitate Endovascular Procedures?
 
3:35 PM - 3:40 PM Panel Discussion
Moderator(s): TBD / TBD / TBD  
3:40 PM - 3:45 PM Debate 12: Medical Treatment Is Best For Most Asymptomatic Patients With Carotid Stenosis
 
3:46 PM - 3:51 PM Debate 12: CEA Or CAS, Not Medical Treatment, Is Best For Most Asymptomatic Patients With >60% Carotid Stenosis
 
3:52 PM - 3:57 PM Interventional Treatment (CAS or CEA) Should Await New Diagnostic Methods: What Is On The Horizon?
 
3:58 PM - 4:03 PM Best Medical Treatment Is Currently The Optimal Management For >60% Carotid Stenosis In Asymptomatic Patients: What Is Needed To Maximize The Benefit Of CAS In Such Patients?
 
4:04 PM - 4:09 PM Value Of Intense Lipid Lowering Treatment In Patients With Asymptomatic Carotid Stenosis
 
4:10 PM - 4:15 PM How To Identify Vulnerable Carotid Plaques In Asymptomatic Patients Noninvasively With Molecular Imaging
 
4:16 PM - 4:21 PM How To Predict Which Asymptomatic Patients Are At High Risk For Stroke So They Can Be Treated Invasively Without Treating All Asymptomatic Patients: Present Status And Future Possibilities
 
4:22 PM - 4:27 PM Effect Of Exercise And Statins On Carotid Plaques: Implications For Invasive Treatment Of Asymptomatic Patients
 
4:28 PM - 4:33 PM Status Of The TACIT Trial: Will We Ever Know The Truth About How Asymptomatic Patients With Carotid Stenosis Should Be Treated?: Will The Stimulus Package Save The Day For TACIT?
 
4:34 PM - 4:39 PM Panel Discussion
END OF SESSION 17
 
SESSION 18 SCHEDULE
Thursday
SESSION 18: UPDATE ON STENT GRAFTS IN THE SFA AND POPLITEAL ARTERIES (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
4:39 PM - 4:44 PM 12-Year Experience With VIABAHN Stent-Grafts For Treatment Of Long SFA Occlusions: Technical Tips And 5 And 10-Year Patency Data
 
4:45 PM - 4:50 PM Single Center And Multicenter Results (VIBRANT Trial) Of VIABAHN Stent-Grafts vs. Uncovered Nitinol Stents For SFA Occlusive Disease
 
4:51 PM - 4:56 PM Edge Stenosis After SFA Stent-Grafting For Occlusive Disease: What Do We Know And What Can Be Done To Prevent Or Treat It: Will Heparin Bonding Improve Results?
 
4:57 PM - 5:02 PM Coverage Of Collaterals With SFA Stent-Grafts: Is It Or Is It Not A Problem?
 
5:03 PM - 5:08 PM Are Reentry Devices Worth The Effort In Complex SFA Occlusions?
 
5:09 PM - 5:14 PM 2-3-Year Results With Tissue Covered Stents For SFA Occlusive Disease: Technical Improvements In The System
 
5:15 PM - 5:20 PM Long-Term Follow-up Of VIABAHN Stent-Grafts To Treat Popliteal Aneurysms: Tips, Tricks, Precautions And When Not To Use
 
5:21 PM - 5:26 PM Panel Discussion
END OF SESSION 18
 
SESSION 19 SCHEDULE
Thursday
SESSION 19: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
5:26 PM - 5:31 PM 2-3-Year Results With Drug Eluting Stents (DES): Does Catch-Up Stenosis And Mortality Occur And Why?
 
5:32 PM - 5:37 PM Midterm Efficacy And Long-Term Outlook With Coronary Drug Eluting Stents And Absorbable Drug Eluting Stents (The ABSORB Trial): Is There A Downside Beside Costs?
  Presenters(s):Martin B. Leon, MD  
5:38 PM - 5:43 PM Vulnerable Plaques: Implications For Vascular Surgeons And Interventionalists And What Can Be Done About Them?
 
5:44 PM - 5:49 PM Findings And Interpretations Of The SYNTAX Trial: Is It A Winner For Stenting Or CABG In Severe Coronary Artery Disease With Triple Vessel Or Left Main Disease?
 
5:50 PM - 5:55 PM Will Biodegradable Stents Replace Drug Eluting Stents?
 
5:56 PM - 6:01 PM Surgical And Endovascular Treatment Of Takayasu’s Arteritis: Which Treatment Should Be Used And When?
 
6:02 PM - 6:07 PM Radiation Exposure To The Interventionalist: Innovations And Precautions To Lessen It
 
6:08 PM - 6:13 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Thursday
SESSION 20: PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
6:13 PM - 6:18 PM Superficial Femoral Artery Access For Endovascular Procedures When The Common Femoral Cannot Be Used Due To Scarring, Disease Or Infection
 
6:19 PM - 6:24 PM Neurological Complications Of TEVAR: How To Prevent And Treat Them
 
6:25 PM - 6:30 PM Advantages Of And Indications For Use Of Bivalirudin Rather Than Heparin For Endovascular Procedures
 
6:31 PM - 6:36 PM Technical Tips On Managing Abdominal Compartment Syndrome And Open Abdomen Treatment After EVAR For Ruptured AAA
 
6:37 PM - 6:42 PM Techniques For Simplified Endovascular Management Of Iatragenic Subclavian Artery Injury
 
6:43 PM - 6:48 PM EMPIRE Trial Of The Gore Parodi Flow Reversal Embolic Protection Device In CAS: Its Particular Value In Symptomatic Patients And Octogenarians
 
6:49 PM - 6:54 PM Technique For Placement Of Large Palmaz Stent For Proximal Neck Problem During EVAR: What Balloon, Sheath And Precautions Are Needed?
 
6:55 PM - 7:00 PM Use Of Covered Palmaz Stent As A Neck Extender In EVAR
  Presenters(s):Ralf R. Kolvenbach, MD  
7:01 PM - 7:06 PM What The Vascular Surgeon Or Interventionalist Needs To Know About Discontinuing Plavix In A Patient With A Drug Eluting Coronary Stent Needing Another Procedure
 
7:07 PM - 7:15 PM Panel Discussion
END OF SESSION 20